Medical Oncologist
CION Cancer Clinics
How intrahepatic cholangiocarcinoma is diagnosed, test by test | CION Cancer Clinics
Intrahepatic cholangiocarcinoma is found on a scan and confirmed with a biopsy. Contrast CT or MRI shows the tumour, blood tests show how the liver is coping, and other scans check for spread. Because it looks so like cancer that spread from elsewhere, tissue is almost always needed. That tissue is also tested for gene changes that can open targeted treatment options. At CION Cancer Clinics in Hyderabad, our oncologists explain liver cancer in plain words and plan care around you and your family.
NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed October 2026, next review due October 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
The short answer
How do doctors confirm intrahepatic cholangiocarcinoma?
With a scan to find and measure the tumour, and a biopsy to prove what it is. Blood tests and further scans then show how far it has spread and how well the liver is working. The biopsy tissue is also sent for molecular testing, because some of these cancers have targeted treatment options.
Why a biopsy is almost always needed
The most common liver cancer, HCC, can often be diagnosed from a special scan alone in a person with cirrhosis. Cholangiocarcinoma cannot. On a scan it looks very like cancer that has spread to the liver from the bowel, stomach, pancreas or breast. Only tissue under a microscope can separate them. Read why a biopsy is needed here but often not for HCC.
Why the hunt for another cancer is part of it
Because spread from elsewhere looks so similar, doctors often check the bowel, stomach, breast or other organs before they settle on a diagnosis. That is careful work, not confusion. This cancer is often mistaken for secondary cancer, and the treatment is different.
A scan report that says "suspicious" or "likely" is not yet a diagnosis.The tests you may have
Which tests are used, and what does each one answer?
Not everyone needs every test. Each one answers a different question.
Ultrasound
Often the first scan, and often where the tumour is first seen. It shows that something is there and whether the bile ducts are widened. It cannot say what the lump is.
Contrast CT and MRI
A CT or MRI with a dye injection shows the size of the tumour, the blood vessels around it and the bile ducts. MRI with a bile duct view, called MRCP, maps the ducts without a tube. These scans decide whether surgery is even a possibility.
Biopsy
A thin needle guided by ultrasound or CT takes a small core of the tumour. A pathologist looks at it and runs stains to confirm it began in the bile ducts. See what happens on the day of a liver biopsy.
Blood tests
Liver function tests, a blood count and clotting tests show how well the liver is coping. Hepatitis B and C tests are routine.
Markers often checked
- CA 19-9, often raised, but also raised by blocked ducts
- CEA, helpful when bowel cancer is a question
- AFP, to look for HCC instead
PET-CT and other scans
A chest CT, and sometimes PET-CT, look for spread to lymph nodes or other organs. Read about PET-CT for bile duct cancer. An endoscopy or colonoscopy may be done to rule out a primary cancer in the gut.
Not sure whether this applies to you?
Ask an oncologistIn what order
What order do the tests usually come in?
Something is seen on a scan
Often an ultrasound done for pain, raised liver enzymes or a health check. You are referred on, and a contrast CT or MRI is arranged.
The full picture of the liver
The better scan shows how many tumours there are, which vessels and ducts are involved, and the state of the rest of the liver. Blood tests are done at the same time.
The biopsy, planned around surgery
If the tumour looks removable, the surgeon may want to see the scans before any needle is used. Sometimes the operation itself provides the tissue. Otherwise a biopsy confirms the diagnosis first.
Staging and molecular tests
Scans of the chest and sometimes PET-CT check for spread. The tumour tissue is sent for molecular profiling. Then the case goes to the tumour board, where surgeons, oncologists and radiologists agree a plan together.
On your report
What do the words on the report mean?
- Space-occupying lesion (SOL)
- A lump or area inside the liver that should not be there. It says nothing yet about what it is.
- Mass-forming
- The most common pattern inside the liver: a solid lump rather than a narrowing along a duct.
- Peripheral enhancement, delayed enhancement
- How the tumour takes up the dye over time. This pattern is typical of cholangiocarcinoma but is seen in some other tumours too.
- Intrahepatic biliary dilatation
- Widened bile ducts inside the liver, usually because something is blocking them further down.
- Adenocarcinoma, CK7 positive, CK20 negative
- The pathologist's words. A gland-forming cancer, with stain results that point towards the bile ducts and away from the bowel.
- Satellite lesions
- Small tumours close to the main one. They matter when surgeons decide whether the cancer can be removed.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Did you know
Bile duct cancers should have their DNA tested, called molecular profiling, because some carry changes such as FGFR2 fusions or IDH1 mutations that have targeted options. Not every tumour has one, and a result does not promise a treatment, but asking early saves a second biopsy later. Read why every biliary cancer should be molecularly tested.
Being straight with you
What this page cannot tell you
It cannot read your scan or your biopsy report. The same words can mean different things depending on the full set of images, the stains and your history. Take every report and every CD to the doctor who will plan your care, rather than searching each word online.
Who this does not apply to
If the cancer is in the bile duct outside the liver, the tests lean more on MRCP, ERCP and brushings from inside the duct. See MRCP, ERCP and cholangioscopy. If you have cirrhosis and a scan typical of HCC, the rules are different again. If the cancer began elsewhere and spread to the liver, the diagnosis is led by that original cancer.
Who arranges the tests
CION's oncologists review your reports and plan which tests you still need. Scans, biopsy, pathology and endoscopy are arranged through accredited partner hospitals and diagnostic centres. Your team will tell you where each one takes place.
If tests have been done in different places, bring them all. A complete set often avoids repeating a scan.Questions we are asked
Common questions about diagnosing cholangiocarcinoma
Can a CT scan alone diagnose cholangiocarcinoma?
A CT or MRI can strongly suggest it, but it cannot prove it. The appearance overlaps with cancer that has spread to the liver from another organ. A biopsy, or tissue taken at surgery, is needed to confirm the diagnosis and to allow molecular testing for treatment.
Is the liver biopsy risky?
It is a common, carefully planned procedure, but not risk-free. The main risk is bleeding, which is why clotting tests are checked first. Some people worry the needle spreads the cancer. That is uncommon, and the surgeon is often consulted before a biopsy if removal is possible.
My CA 19-9 is high. Does that confirm it?
No. CA 19-9 rises with blocked bile ducts, infection and several other cancers, and it can be normal in people who do have this cancer. It is one clue, and more useful for following treatment later. Read what CA 19-9 does and does not tell you.
Why are they checking my bowel and stomach?
Because a cancer that spread to the liver from the bowel or stomach can look the same on a scan and even under the microscope. Ruling those out means you get the right treatment for the right cancer. It does not mean the doctors are guessing.
The biopsy was inconclusive. What now?
It happens when the needle catches too little tumour or mostly scar tissue. The usual options are a repeat biopsy, sending the slides for a second pathology opinion, or going ahead with surgery if the tumour is clearly removable. Your team will explain which fits.
Is PET-CT always needed?
No. A contrast CT of the chest and abdomen, with MRI of the liver, is often enough. PET-CT is added when doctors need to check for hidden spread, especially before a major operation. It is a decision made for each person.
Does molecular testing need a fresh biopsy?
Usually not. The tissue block from the first biopsy or operation is stored and can be tested. If the sample was very small, it may not be enough, which is why it helps to ask about molecular testing before the biopsy is done.
Can I get a second opinion on the diagnosis?
Yes, and with a rare cancer it is reasonable. Bring the scan CDs, reports and biopsy slides or blocks. CION's oncologists can review them, and the tumour board can arrange a second pathology review through a partner laboratory where needed.
Your Specialists
Meet CION's liver cancer specialists. Bring your scan reports and liver blood tests.
Our medical and surgical oncologists plan liver cancer care together, weighing the tumour and how well your liver works before choosing surgery, a liver-directed procedure or medicines.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- American Cancer Society — Bile Duct Cancer Diagnostic Tests
- National Cancer Institute — What Is Bile Duct Cancer (Cholangiocarcinoma)?
- American Cancer Society — Bile Duct Cancer Targeted Therapy
- National Cancer Institute — Tumor Markers
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Why a biopsy is needed here but often not for HCCThe reason tissue matters so much in this cancerWhy every biliary cancer should be molecularly testedWhat the gene tests look for and why to ask earlyStaging intrahepatic cholangiocarcinomaThe next step once the diagnosis is confirmedSymptoms of intrahepatic cholangiocarcinomaThe signs that usually start the tests
Talk to us
Not sure which test should come next?
Share the scans and reports you already have. Our oncologists will tell you what is still needed and help arrange it through partner centres. One helpline serves every CION centre.